FDA proposal on overseas device trials gets industry pushback

06/4/2013 | MassDevice.com (Boston)

An FDA proposed rule that would subject medical-device trials conducted outside the U.S. to additional ethical review has drawn industry concerns. In a letter to the FDA, AdvaMed said some of the plans may conflict with policies in other countries and urged the FDA to wait for development of "a harmonized, international medical device and IVD GCP guideline."

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX